Please login to the form below

Not currently logged in
Email:
Password:

burns treatment

This page shows the latest burns treatment news and features for those working in and with pharma, biotech and healthcare.

Ireland's Mallinckrodt buys US regenerative medicine firm

Ireland's Mallinckrodt buys US regenerative medicine firm

Ireland's Mallinckrodt buys US regenerative medicine firm. Stratatech’ s StrataGraft in phase III testing for burns treatment. ... Ireland's Mallinckrodt Pharma has continued its acquisitive streak with a deal to buy Stratatech, a US firm developing a

Latest news

  • Herceptin can treat stomach cancer

    Advanced stomach cancer is a devastating disease for which there are currently few treatment options," said William M. ... Burns, CEO of Roche's Pharmaceuticals Division. Stomach cancer is the second most common cause of cancer-related death in the world.

  • Teva invests USD 100m in startup medical technology company

    Mediwound, which is also based in Israel, specialises in technology to treat burns. ... Ruben Krupik, CEO of Clal Biotechnology Industries, said that the burns treatment market was worth USD 400-500m annually.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics